In silver investing news today (Wednesday, Feb. 1), silver prices are down 0.42% and trading at $17.47 per ounce. That's a drop from yesterday's close of $17.54 – the highest settlement for an active futures contract since Nov. 10, 2016.
But the biggest silver price news of the day has to do with the metal's final January numbers. And these numbers support Money Morning Resource Specialist Peter Krauth's prediction that the price of silver will climb another 26% in 2017.
Here's more on silver's January performance…
The Biggest Silver Investing News TodayThe biggest news today is that silver prices just posted their biggest monthly gain in seven months.
According to data from FactSet, the price of silver rose 9.7% in January. That widely outpaced the gold price's 5.2% rise. It also marks silver's biggest monthly gain for active futures contracts since June 2016. During that month, silver prices surged 15.9%.
Best Gold Stocks To Buy For 2019: M.D.C. Holdings, Inc.(MDC)
Advisors' Opinion:- [By Tyler Crowe]
Buying a new home isn't something you go out and do every day. So, as you can imagine, sales at homebuilders can be quite seasonal and a bit lumpy at times. One quarter of weak sales numbers isn't that big of a deal, really. However, this was the second quarter in a row where M.D.C. Holdings (NYSE:MDC) didn't look that great, especially when you consider the backdrop of an incredibly robust housing market and other homebuilders posting double-digit growth rates.
- [By Tyler Crowe]
In the first quarter of this past year, something seemed a bit off in MDC Holdings' (NYSE:MDC) earnings report. Even though the first quarter is traditionally slow for home sales in general, MDC's new home sales slid for two straight quarters, and revenue was up on selling prices alone.
- [By Max Byerly]
M.D.C. Holdings, Inc. (NYSE:MDC) Director Michael A. Berman sold 20,000 shares of M.D.C. stock in a transaction on Thursday, August 23rd. The shares were sold at an average price of $32.67, for a total value of $653,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
- [By Ethan Ryder]
Mediclinic International (LON:MDC) had its price target reduced by Barclays from GBX 700 ($9.12) to GBX 660 ($8.60) in a research report sent to investors on Friday. They currently have an overweight rating on the stock.
- [By Joseph Griffin]
M.D.C. (NYSE:MDC) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a report released on Monday.
Best Gold Stocks To Buy For 2019: New Oriental Education & Technology Group, Inc.(EDU)
Advisors' Opinion:- [By Joseph Griffin]
Education Management (OTCMKTS: EDMC) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.
- [By Ethan Ryder]
Strayer Education (NASDAQ: STRA) and New Oriental Education & Tech Grp (NYSE:EDU) are both consumer discretionary companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, earnings, institutional ownership and profitability.
- [By Shane Hupp]
EduCoin (CURRENCY:EDU) traded 1.8% lower against the U.S. dollar during the 1 day period ending at 19:00 PM E.T. on October 6th. EduCoin has a total market cap of $0.00 and $1.09 million worth of EduCoin was traded on exchanges in the last day. During the last seven days, EduCoin has traded 5.9% lower against the U.S. dollar. One EduCoin token can currently be bought for approximately $0.0004 or 0.00000007 BTC on exchanges.
Best Gold Stocks To Buy For 2019: Enova International, Inc.(ENVA)
Advisors' Opinion:- [By Shane Hupp]
Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
- [By Max Byerly]
Get a free copy of the Zacks research report on Enova International (ENVA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Get a free copy of the Zacks research report on Enova International (ENVA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.
- [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
- [By Joseph Griffin]
Enova International (NYSE:ENVA) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Enova International, Inc. is a provider of online financial services. It offers loans to customers in the United States and in the United Kingdom, Australia and Canada. The Company’s customers include consumers who have bank accounts but use alternative financial credit services because of their limited access to more traditional consumer credit from banks, thrifts, credit card companies and other lenders. Enova International, Inc is headquartered in Chicago. “
No comments:
Post a Comment